RHK — Rhoen Klinikum AG Income Statement
0.000.00%
Last trade - 00:00
- €863.51m
- €538.20m
- €1.46bn
- 79
- 65
- 64
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,304 | 1,360 | 1,402 | 1,446 | 1,464 |
Cost of Revenue | |||||
Gross Profit | 896 | 938 | 972 | 1,000 | 976 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,247 | 1,350 | 1,372 | 1,410 | 1,423 |
Operating Profit | 56.9 | 10.4 | 30 | 36.3 | 40.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 54.2 | 3.93 | 27.4 | 33.6 | 47.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 44.5 | 2.46 | 30.2 | 26.9 | 40.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 43.3 | 1.45 | 28.3 | 25.1 | 38.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 43.3 | 1.45 | 28.3 | 25.1 | 38.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.648 | 0.118 | 0.431 | 0.337 | 0.581 |
Dividends per Share |